Harry Stylli, chief executive and president, Sequenom, San Diego, California
Virginia Gewin
Nature, 2005, vol. 436, issue 7048, 300-300
Abstract:
Entrepreneur charts course from pharma to biotech
Date: 2005
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/nj7048-300a Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:436:y:2005:i:7048:d:10.1038_nj7048-300a
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/nj7048-300a
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().